Clinical trials

SEVICE

Patient recruitment

Recruitment of patients with cervical cancer, head & neck cancer & anal cancer

• This study is a single center, open, single arm, dose increasing clinical trial (IIT) initiated by researchers to evaluate the safety, tolerance and preliminary effectiveness of CRTE7A2-01 TCR-T cell injection in HPV16 positive patients with advanced cervical cancer, anal ...

• HPV 16 positive TCR-T cell injection / CRTE7A2-01 TCR-T Cell Injection

Recruitment of patients with cervical cancer, head & neck cancer & anal cancer

• This study is a single center, open, single arm, dose increasing clinical trial (IIT) initiated by researchers to evaluate the safety, tolerance and preliminary effectiveness of CRTE7A2-01 TCR-T cell injection in HPV16 positive patients with advanced cervical cancer, anal ...

• HPV 16 positive TCR-T cell injection / CRTE7A2-01 TCR-T Cell Injection

Recruitment of patients with cervical cancer, head & neck cancer & anal cancer

• This study is a single center, open, single arm, dose increasing clinical trial (IIT) initiated by researchers to evaluate the safety, tolerance and preliminary effectiveness of CRTE7A2-01 TCR-T cell injection in HPV16 positive patients with advanced cervical cancer, anal ...

• HPV 16 positive TCR-T cell injection / CRTE7A2-01 TCR-T Cell Injection

Recruitment of patients with cervical cancer, head & neck cancer & anal cancer

• This study is a single center, open, single arm, dose increasing clinical trial (IIT) initiated by researchers to evaluate the safety, tolerance and preliminary effectiveness of CRTE7A2-01 TCR-T cell injection in HPV16 positive patients with advanced cervical cancer, anal ...

• HPV 16 positive TCR-T cell injection / CRTE7A2-01 TCR-T Cell Injection

Recruitment of patients with cervical cancer, head & neck cancer & anal cancer

• This study is a single center, open, single arm, dose increasing clinical trial (IIT) initiated by researchers to evaluate the safety, tolerance and preliminary effectiveness of CRTE7A2-01 TCR-T cell injection in HPV16 positive patients with advanced cervical cancer, anal ...

• HPV 16 positive TCR-T cell injection / CRTE7A2-01 TCR-T Cell Injection

Recruitment of patients with cervical cancer, head & neck cancer & anal cancer

• This study is a single center, open, single arm, dose increasing clinical trial (IIT) initiated by researchers to evaluate the safety, tolerance and preliminary effectiveness of CRTE7A2-01 TCR-T cell injection in HPV16 positive patients with advanced cervical cancer, anal ...

• HPV 16 positive TCR-T cell injection / CRTE7A2-01 TCR-T Cell Injection

Clinical trial process

Obtaining informedconsent

Collect the medical records, laboratory and imaging results of
Antigen and HLA type testing

Collect the medical records, laboratory and imaging results of
Leukapheresis

Collect the medical records, laboratory and imaging results of

TCR-T preparation

Collect the medical records, laboratory and imaging results of

Follow up

Collect the medical records, laboratory and imaging results of
TCR-T transfusion

Collect the medical records, laboratory and imaging results of
Follow up

Collect the medical records, laboratory and imaging results of

TCR-T preparation

Collect the medical records, laboratory and imaging results of